Tag: Nasdaq:IMA

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA” at market open on Monday, July 28, 2025

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsNasdaq:IMA

Remittix Confirms Q3 2025 Beta Wallet Launch with Solana and Ethereum Support, Presale Surpasses $17.3 Million

Remittix Announces Q3 2025 Beta Wallet Launch with Solana Network Support, Raising Over $17.3 Million in Ongoing Presale

No KYC. 100x Leverage. Double Deposit Bonus Match. Crypto Futures Trading Made Easy on BexBack.

Tag: Nasdaq:IMA

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us